Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors
- PMID: 39214095
- DOI: 10.1016/j.ccell.2024.08.005
Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors
Abstract
Human tumors are intricate ecosystems composed of diverse genetic clones and malignant cell states that evolve in a complex tumor micro-environment. Single-cell RNA-sequencing (scRNA-seq) provides a compelling strategy to dissect this intricate biology and has enabled a revolution in our ability to understand tumor biology over the last ten years. Here we reflect on this first decade of scRNA-seq in human tumors and highlight some of the powerful insights gleaned from these studies. We first focus on computational approaches for robustly defining cancer cell states and their diversity and highlight some of the most common patterns of gene expression intra-tumor heterogeneity (eITH) observed across cancer types. We then discuss ambiguities in the field in defining and naming such eITH programs. Finally, we highlight critical developments that will facilitate future research and the broader implementation of these technologies in clinical settings.
Copyright © 2024. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests M.L.S. is equity holder, scientific co-founder and advisory board member of Immunitas Therapeutics. I.T. is an advisory board member of Immunitas Therapeutics.
Similar articles
-
Single-Cell RNA Sequencing for Studying Human Cancers.Annu Rev Biomed Data Sci. 2023 Aug 10;6:1-22. doi: 10.1146/annurev-biodatasci-020722-091857. Epub 2023 Apr 11. Annu Rev Biomed Data Sci. 2023. PMID: 37040737 Review.
-
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.Nat Med. 2020 May;26(5):792-802. doi: 10.1038/s41591-020-0844-1. Epub 2020 May 11. Nat Med. 2020. PMID: 32405060 Free PMC article.
-
Biological and Medical Importance of Cellular Heterogeneity Deciphered by Single-Cell RNA Sequencing.Cells. 2020 Jul 22;9(8):1751. doi: 10.3390/cells9081751. Cells. 2020. PMID: 32707839 Free PMC article. Review.
-
DeSide: A unified deep learning approach for cellular deconvolution of tumor microenvironment.Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2407096121. doi: 10.1073/pnas.2407096121. Epub 2024 Nov 8. Proc Natl Acad Sci U S A. 2024. PMID: 39514318 Free PMC article.
-
Single-Cell Transcriptomic Analysis of Tumor Heterogeneity.Trends Cancer. 2018 Apr;4(4):264-268. doi: 10.1016/j.trecan.2018.02.003. Epub 2018 Mar 9. Trends Cancer. 2018. PMID: 29606308 Free PMC article. Review.
Cited by
-
Enhancing detection and monitoring of circulating tumor cells: Integrative approaches in liquid biopsy advances.J Liq Biopsy. 2025 Apr 29;8:100297. doi: 10.1016/j.jlb.2025.100297. eCollection 2025 Jun. J Liq Biopsy. 2025. PMID: 40453103 Free PMC article. Review.
-
Differentiable graph clustering with structural grouping for single-cell RNA-seq data.Bioinformatics. 2025 Jul 1;41(7):btaf347. doi: 10.1093/bioinformatics/btaf347. Bioinformatics. 2025. PMID: 40511990 Free PMC article.
-
Multi-Omics Analysis Reveals the transforming growth factor-β Signaling-Driven Multicellular Interactions with Prognostic Relevance in Cervical Cancer Progression.J Cancer. 2025 Jun 20;16(9):2857-2876. doi: 10.7150/jca.114505. eCollection 2025. J Cancer. 2025. PMID: 40657372 Free PMC article.
-
New horizons at the interface of artificial intelligence and translational cancer research.Cancer Cell. 2025 Apr 14;43(4):708-727. doi: 10.1016/j.ccell.2025.03.018. Cancer Cell. 2025. PMID: 40233719 Review.
-
Plasticity of tumor cell immunogenicity: is it druggable?J Immunother Cancer. 2025 Apr 23;13(4):e011859. doi: 10.1136/jitc-2025-011859. J Immunother Cancer. 2025. PMID: 40274282 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical